alprazolam has been researched along with Chronic Kidney Failure in 5 studies
Alprazolam: A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)
alprazolam : A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug.
Excerpt | Relevance | Reference |
---|---|---|
" There was also a tendency for a later Tmax and a longer elimination half-life in CAPD patients than in normal subjects or HD patients." | 2.67 | Alprazolam in end-stage renal disease: I. Pharmacokinetics. ( Kroboth, PD; Piraino, B; Schmith, VD; Smith, RB, 1991) |
"6." | 1.28 | Platelet-activating factor mediates glycerol-induced acute renal failure in rats. ( Bernabeu, F; Braquet, P; Gómez-Garre, D; López-Farré, A; López-Novoa, JM; Perez-Rodrigo, P; Ramón y Cajal, S, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Güner Can, M | 1 |
Ilgaz Koçyiğit, Ö | 1 |
Aksu, U | 1 |
Özer, A | 1 |
Toraman, F | 1 |
Schmith, VD | 2 |
Piraino, B | 2 |
Smith, RB | 3 |
Kroboth, PD | 2 |
López-Farré, A | 1 |
Gómez-Garre, D | 1 |
Bernabeu, F | 1 |
Ramón y Cajal, S | 1 |
Perez-Rodrigo, P | 1 |
Braquet, P | 1 |
López-Novoa, JM | 1 |
Ochs, HR | 1 |
Greenblatt, DJ | 1 |
Labedzki, L | 1 |
3 trials available for alprazolam and Chronic Kidney Failure
Article | Year |
---|---|
Effect of Alprazolam on Redox Status in Renal Transplantation Donors and Recipients.
Topics: Adult; Aged; Alprazolam; Female; GABA Modulators; Humans; Kidney Failure, Chronic; Kidney Transplant | 2017 |
Alprazolam in end-stage renal disease. II. Pharmacodynamics.
Topics: Adult; Alprazolam; Double-Blind Method; Female; Humans; Kidney Failure, Chronic; Male; Motor Activit | 1992 |
Alprazolam in end-stage renal disease: I. Pharmacokinetics.
Topics: Adult; Alprazolam; Double-Blind Method; Female; Humans; Kidney Failure, Chronic; Male; Peritoneal Di | 1991 |
2 other studies available for alprazolam and Chronic Kidney Failure
Article | Year |
---|---|
Platelet-activating factor mediates glycerol-induced acute renal failure in rats.
Topics: Acute Kidney Injury; Alprazolam; Animals; Disease Models, Animal; Diterpenes; Ginkgolides; Glomerula | 1990 |
Alprazolam kinetics in patients with renal insufficiency.
Topics: Adolescent; Adult; Aged; Alprazolam; Female; Humans; Kidney Failure, Chronic; Kinetics; Male; Middle | 1986 |